Michael King

Michael King currently serves as the Chief Financial Officer at Scipher Medicine, utilizing AI and molecular data for patient therapy matching in autoimmune diseases. In addition to this role, King holds various advisory and board positions, including being a Board Member at Regio Biosciences and a Co-Founder of The BioForge Group, LLC, which specializes in biotechnology advisory services. King has also contributed as CFO-Advisor for both Black Canyon Bio and Primera Therapeutics, focusing on innovative gene editing technologies. Previously, King held leadership roles, such as Chief Financial Officer at Mayflower Bioventures and Chief Business Officer at Adaptive Phage Therapeutics, which specialized in combatting multi-drug resistant bacteria. King is a partner at Hibiscus Biotechnology and has extensive experience with King Partners, a firm dedicated to addressing the needs of biotech companies. Academically, King holds an MBA from Columbia Business School and a BA from Wesleyan University.